HP Hartung

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Ludwig Kappos, C. H. Polman, Mark S. Freedman et al. · Neurology · 2006 · 672 citations

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Vittorio Martinelli, M. Rodegher, Lucia Moiola et al. · The Lancet · 2009 · 585 citations

Neurological Disorder, Medicine, Clinical Neurology +8

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Ludwig Kappos, Chris H. Polman, Mark S. Freedman et al. · American Journal of Ophthalmology · 2006 · 551 citations

Autoimmune Disease, Mcdonald Ms, Immunodeficiencies +4

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle, Giulio Disanto, Ruth Dobson et al. · Multiple Sclerosis Journal · 2015 · 290 citations

A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS

Michel Clanet, Ernst‐Wilhelm Radue, Ludwig Kappos et al. · Neurology · 2002 · 218 citations